Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;65(11):1165-1175.
doi: 10.4103/indianjpsychiatry.indianjpsychiatry_585_23. Epub 2023 Nov 24.

Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers

Affiliations

Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers

Sandeep Grover et al. Indian J Psychiatry. 2023 Nov.

Abstract

Background: Despite clozapine being the gold standard for treating patients suffering from treatment-resistant schizophrenia, the experience and attitude of patients receiving clozapine for a long duration and their caregivers have not been evaluated, especially in India and other low-middle-income countries. Also, no standardized scale has been validated for such assessment.

Objective: This study aimed to evaluate the perception regarding clozapine among patients and their caregivers. We also attempted to evaluate the factor structure of the scale for such assessment.

Methods: A total of 172 consenting patients who have been receiving clozapine for ≥1 year and their caregivers were evaluated on self-designed questionnaires (patient and caregiver versions containing 44 and 47 items, respectively) to assess various aspects of their experiences about clozapine use.

Results: A majority (70-80%) of patients and caregivers reported improvement in psychotic symptoms, mood symptoms, and overall functioning with starting of clozapine. However, about 40% of the patients reported cognitive side effects, and 20-25% reported disabling side effects like lethargy, forgetfulness and decreased attention, and distress related to blood testing after starting of clozapine. Factor analysis of the questionnaires yielded five- and seven-factor models for the experience and attitude of the patients and the caregivers, respectively. The positive experiences were associated clinical and functional improvement, lower disability, and improvement in functioning as well as the self-reported perceived improvement by the patient and caregiver.

Conclusion: This study suggests that patients tend to have an overall positive experience and attitude about using clozapine. The caregivers also report the beneficial effect on the caregiving. A good level of agreement was seen between the experience of patients, caregivers, and clinician-rated improvement in the psychopathology and functioning.

Keywords: Attitude; caregivers; clozapine; experience; patients.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

Cited by

References

    1. World Health Organization Schizophrenia. [Last accessed on 2023 Feb 28];2022 Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia .
    1. Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, et al. Treatment-resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174:216–29. - PMC - PubMed
    1. Taylor DM. Clozapine for treatment-resistant schizophrenia: Still the gold standard? CNS Drugs. 2017;31:177–80. - PubMed
    1. Grover S, Balachander S, Chakarabarti S, Avasthi A. Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from India. Asian J Psychiatr. 2015;18:57–65. - PubMed
    1. Grover S, Hazari N, Chakrabarti S, Avasthi A. Delay in initiation of clozapine: A retrospective study from a tertiary care hospital in North India. Psychiatry Res. 2015;226:181–5. - PubMed